Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JTA-004 in Symptomatic Knee Osteoarthritis
NCT04333160Phase 3Completed
- Sponsor
- BioSenic
- Start
- Mar 2020
- Primary completion
- Mar 2021
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 7
01
Overview
A Phase 3 trial of JTA-004 in knee osteoarthritis (OA), sponsored by BioSenic. Started Mar 2020; status: completed.
02
Drugs
JTA-004
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT04333160.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04333160.